Free Trial

NeuroPace (NPCE) SEC Filings & 10K Form

NeuroPace logo
$11.79 +0.10 (+0.86%)
Closing price 04:00 PM Eastern
Extended Trading
$11.80 +0.01 (+0.04%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NeuroPace SEC Filings

DateFilerForm TypeView
04/23/2025
6:44 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
6:45 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:38 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
5:10 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
4:16 PM
Becker Joel (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
4:18 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:08 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:09 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:29 PM
NeuroPace (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
4:05 PM
NeuroPace (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
5:51 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
5:52 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
5:31 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
4:41 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
8:51 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:00 AM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
5:33 AM
NeuroPace (Filer)
Form 424B5
02/14/2025
5:08 AM
NeuroPace (Filer)
Form 424B5
02/14/2025
5:11 AM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
11:50 AM
MORGAN STANLEY (Filed by)
NeuroPace (Subject)
Form SCHEDULE 13G/A
01/31/2025
6:16 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
3:11 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
3:26 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
5:08 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:25 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:30 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:43 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:56 PM
Huennekens R Scott (Reporting)
NeuroPace (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
3:57 PM
Huennekens R Scott (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:38 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:30 PM
NeuroPace (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/04/2024
3:51 PM
Kent Lake PR LLC (Filed by)
NeuroPace (Subject)
Form SCHEDULE 13G
10/28/2024
6:02 AM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/24/2024
1:23 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
9:35 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
9:17 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:15 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:05 PM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:14 PM
NeuroPace (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
4:30 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:17 PM
NeuroPace (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.

Click here to access the full report now.
05/08/2024
3:16 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NPCE) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners